1 – 6 of 6
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
- Standardized added metabolic activity (SAM) IN 18F-FDG PET assessment of treatment response in colorectal liver metastases (
- 2012
- Value of DCE-MRI and FDG-PET/CT in the prediction of response to preoperative chemotherapy with bevacizumab for colorectal liver metastases (
- 2011
- FDG-PET is a predictor of metabolic response to chemotherapy in metastatic colorectal cancer (mCRC) (
- An evaluation of FDG-PET as a predictor of metabolic response to chemotherapy in metastatic colorectal cancer patients (mCRC) (
- PET as a predictor of metabolic response to antiangiogenic therapy in metastatic colorectal cancer (mCRC) (
- Preoperative chemotherapy for colorectal liver metastases: prediction of response by DCE-MRI abd FDG-PET/CT? (